l
OMo
ARc
PS
NR565Phar
macologyMidter
m St
udyGui
de
2022\2022
Ad
van
cedPh
arma
col
ogyF
und
ame
nta
ls(
Cha
mbe
rla
inUn
ive
rsi
ty
)
Whatther
api
esarepref
err
edme
thodf
ort
rea
tin
gch
ron
icp
ain
?Se
lec
tal
lth
ata
ppl
y.
B)
No n
opioi
dmedica
tion
s
C)
No nph
armacol
ogi
c
Wh i
chst
ate
me nt
(s)bestdescr
ibeempath
ya sastr
ate
gyi napa
tie
nt-
cen
ter
ed
tr
eatmen
t?Sele
cta l
lthatapp
ly.
A)Hel
pspat
ien
tsfeelthatt
heyaren
'tal
oneinth
eire
xperi
ence
D)Hel
pspat
ien
tsde v
elopsenseoftr
ustandfee
lunder
stood
Kare
nL ee,
a63-ye
a rol
dwoman,ha
so st
eoar
thr
it
is.Wh
atnon
pha
rma
col
ogi
c
tr
eatmentshou
ldbeconsi
der
ed?Sel
ecttheb
estanswe
r.
B)Ex
e r
ci
se
Whic
ho fthef o
llo
wi ngsta
tementscorr
ectl
yd es
cri
betheris
ksa ndbenefi
tsof
nono
pioidme dicati
ons?Selec
ta l
lth
atapply.
A)
Non opi
oidme dicat
ionsareassoci
ate
dwi t
hcerta
inri
sks,
wh i
chincl
udesp a
tie
nts
wi
thce r
tai
nc omorbidi
ti
es
B)
No n
o pi
oidme dicat
ionsarenotgener
all
yassoci
atedwit
hdevelopmentof
su
bstanceu s
ed isorder
D)
No nopi
oidme dicat
ionscanenhancetheeff
ecti
venes
sofop i
oi
dt he
rapy
Al
anSayedhasne u
ropath
icpain
.Wh atnonopi
oidmedi
cat
ion
ssh
oul
dbe
co
nsi
deredforhi
streatment
?Se l
ectal
lthatappl
y.
A)
Tri
cycl
i
ca nt
ide
p r
essant
s(TCAs)
B)
Topi
call
idocai
ne
C)
Ser
otoni
na ndnorep
inephr
iner
eupta
k ein
h i
bi
tor
s(SNRI
s)
D)
Gabapent
in
Howma nyde
fin
edc r
it
eri
aneedtobeme tac
cordi
ngt
otheDia
gno
sti
can
d
St
ati
sti
calManual
ofMe n
tal
Disord
ers,Fi
ft
hE d
iti
on(
DSM-5)t
obe
di
agnosedwi
thOpioi
dUseDisor
der(OUD)?
, A)
Atl
eas
ttwooft
hed
efi
nedc
ri
te
riawi
thi
nas
ing
ley
ear
Whic
ho ft hefoll
owinginte
rventi
onsa r
es uggest
edi fyo
ususpectOUDinapat
ien
t?
Sel
ecta l
lthatapply.
A)
PerformUr i
n eDrugTesti
n g(
UDT)a ndre v
iewdatafromyourst
ate'
s
pr
escri
p t
iondrugmo nitor
ingprogra
m( PDMP)
B)
Uset heDSM- 5c r
it
eri
atoa ssessfortheprese
nceofOUDa nd/orarr
angef
or
as
sessme n
twithas ubstanceusedisorderspec
ial
i
s t
D)
Discussy ourconcernwithyourpati
enta n
dp r
ovi
d eanopport
unit
yfort
hemto
di
scl
os ea n
yre l
atedconcernsorproble
ms
Wh atme dicatio
nsa reuse
da smedi
cat
ionassi
ste
dthera
py(MAT)fo
rOUD?Sel
ect
allt
h atap pl
y.
A)Me t
h adon e
B)Buprenor phi
ne
D)Na l
trexone
Wh i
chi sth efol
lowingconsi
der
ati
onsar
erelev
antformedi
cat
ion
-ass
ist
edt
her
apy
(MAT) ?Se lectal
lthatappl
y.
A)Patiente ducat
ion
B)Co-occu rr
ingdisor
d e
rs
C)I
nteg r
ationofp harmacol
ogi
candnonphar
macolog
icth
era
pie
s
D)Referralstohigherle
vel
sofcar
eifnee
d e
d
Wh i
chofth
efoll
owin
grequi
resawai
vert
oa dmi
nis
tero
uts
ideofa
nop
ioi
d
tr
eatmentpr
ogram?Sel
ectt
hebesta
nswer.
B)Bupr
enor
phin
e
Whic
hofth
efoll
owi
ngarethemosti
mporta
ntcompo
nen
tso
fmo
nit
ori
ngt
he
sa
fetyo
fopi
oidpr
escr
ibi
ng?Sel
ectal
lth
atapp
ly.
Down
loa
dedb
yma
rlonma
rlonJ
uni
or(
ben
kig
och
i@g
mai
l
.com)
OMo
ARc
PS
NR565Phar
macologyMidter
m St
udyGui
de
2022\2022
Ad
van
cedPh
arma
col
ogyF
und
ame
nta
ls(
Cha
mbe
rla
inUn
ive
rsi
ty
)
Whatther
api
esarepref
err
edme
thodf
ort
rea
tin
gch
ron
icp
ain
?Se
lec
tal
lth
ata
ppl
y.
B)
No n
opioi
dmedica
tion
s
C)
No nph
armacol
ogi
c
Wh i
chst
ate
me nt
(s)bestdescr
ibeempath
ya sastr
ate
gyi napa
tie
nt-
cen
ter
ed
tr
eatmen
t?Sele
cta l
lthatapp
ly.
A)Hel
pspat
ien
tsfeelthatt
heyaren
'tal
oneinth
eire
xperi
ence
D)Hel
pspat
ien
tsde v
elopsenseoftr
ustandfee
lunder
stood
Kare
nL ee,
a63-ye
a rol
dwoman,ha
so st
eoar
thr
it
is.Wh
atnon
pha
rma
col
ogi
c
tr
eatmentshou
ldbeconsi
der
ed?Sel
ecttheb
estanswe
r.
B)Ex
e r
ci
se
Whic
ho fthef o
llo
wi ngsta
tementscorr
ectl
yd es
cri
betheris
ksa ndbenefi
tsof
nono
pioidme dicati
ons?Selec
ta l
lth
atapply.
A)
Non opi
oidme dicat
ionsareassoci
ate
dwi t
hcerta
inri
sks,
wh i
chincl
udesp a
tie
nts
wi
thce r
tai
nc omorbidi
ti
es
B)
No n
o pi
oidme dicat
ionsarenotgener
all
yassoci
atedwit
hdevelopmentof
su
bstanceu s
ed isorder
D)
No nopi
oidme dicat
ionscanenhancetheeff
ecti
venes
sofop i
oi
dt he
rapy
Al
anSayedhasne u
ropath
icpain
.Wh atnonopi
oidmedi
cat
ion
ssh
oul
dbe
co
nsi
deredforhi
streatment
?Se l
ectal
lthatappl
y.
A)
Tri
cycl
i
ca nt
ide
p r
essant
s(TCAs)
B)
Topi
call
idocai
ne
C)
Ser
otoni
na ndnorep
inephr
iner
eupta
k ein
h i
bi
tor
s(SNRI
s)
D)
Gabapent
in
Howma nyde
fin
edc r
it
eri
aneedtobeme tac
cordi
ngt
otheDia
gno
sti
can
d
St
ati
sti
calManual
ofMe n
tal
Disord
ers,Fi
ft
hE d
iti
on(
DSM-5)t
obe
di
agnosedwi
thOpioi
dUseDisor
der(OUD)?
, A)
Atl
eas
ttwooft
hed
efi
nedc
ri
te
riawi
thi
nas
ing
ley
ear
Whic
ho ft hefoll
owinginte
rventi
onsa r
es uggest
edi fyo
ususpectOUDinapat
ien
t?
Sel
ecta l
lthatapply.
A)
PerformUr i
n eDrugTesti
n g(
UDT)a ndre v
iewdatafromyourst
ate'
s
pr
escri
p t
iondrugmo nitor
ingprogra
m( PDMP)
B)
Uset heDSM- 5c r
it
eri
atoa ssessfortheprese
nceofOUDa nd/orarr
angef
or
as
sessme n
twithas ubstanceusedisorderspec
ial
i
s t
D)
Discussy ourconcernwithyourpati
enta n
dp r
ovi
d eanopport
unit
yfort
hemto
di
scl
os ea n
yre l
atedconcernsorproble
ms
Wh atme dicatio
nsa reuse
da smedi
cat
ionassi
ste
dthera
py(MAT)fo
rOUD?Sel
ect
allt
h atap pl
y.
A)Me t
h adon e
B)Buprenor phi
ne
D)Na l
trexone
Wh i
chi sth efol
lowingconsi
der
ati
onsar
erelev
antformedi
cat
ion
-ass
ist
edt
her
apy
(MAT) ?Se lectal
lthatappl
y.
A)Patiente ducat
ion
B)Co-occu rr
ingdisor
d e
rs
C)I
nteg r
ationofp harmacol
ogi
candnonphar
macolog
icth
era
pie
s
D)Referralstohigherle
vel
sofcar
eifnee
d e
d
Wh i
chofth
efoll
owin
grequi
resawai
vert
oa dmi
nis
tero
uts
ideofa
nop
ioi
d
tr
eatmentpr
ogram?Sel
ectt
hebesta
nswer.
B)Bupr
enor
phin
e
Whic
hofth
efoll
owi
ngarethemosti
mporta
ntcompo
nen
tso
fmo
nit
ori
ngt
he
sa
fetyo
fopi
oidpr
escr
ibi
ng?Sel
ectal
lth
atapp
ly.
Down
loa
dedb
yma
rlonma
rlonJ
uni
or(
ben
kig
och
i@g
mai
l
.com)
